ClpX-dependent regulatory pathway exacerbates <i>Streptococcus pyogenes</i> pathogenesis in diabetic skin infection

ABSTRACT Diabetes is associated with impaired immune function and increased susceptibility to severe bacterial infections, yet the pathogen-encoded mechanisms that exacerbate disease in this context remain poorly defined. Streptococcus pyogenes (group A Streptococcus [GAS]) causes invasive skin and soft tissue infections that are disproportionately severe in individuals with diabetes, often accompanied by delayed healing, excessive inflammation, and polymicrobial overgrowth. Here, we investigated how the GAS ClpX-dependent regulatory pathway (CDRP), a global virulence regulator, interacts with diabetic immune dysfunction to shape infection outcomes. Using two murine models of type I diabetes, we show that diabetic mice develop more severe and persistent GAS skin infections characterized by increased bacterial burden, exaggerated inflammatory responses, impaired neutrophil recruitment, excessive neutrophil extracellular trap (NET) accumulation, and frequent polymicrobial infections. Deletion of clpX significantly attenuated GAS virulence in both diabetic and non-diabetic hosts; however, the pathogenic consequences of CDRP were markedly amplified in the diabetic environment. In diabetic mice, CDRP promoted sustained inflammation, altered neutrophil behavior, impaired NET clearance, and enhanced tissue damage, leading to delayed resolution of infection. Mechanistically, ClpX-dependent virulence was associated with dysregulated protease-nuclease activity, excessive NET persistence, and defective neutrophil chemotaxis within diabetic lesions. Together, these findings indicate that while ClpX is a core regulator of GAS virulence, its downstream effects are disproportionately deleterious when host immune clearance is compromised. IMPORTANCE Diabetic patients experience disproportionately severe bacterial infections, yet the microbial mechanisms that exacerbate disease in this immunocompromised context remain incompletely understood. This study demonstrates that the Streptococcus pyogenes ClpX-dependent regulatory pathway, a central regulator of virulence, amplifies tissue damage and inflammatory dysfunction during diabetic skin infection. ClpX-dependent regulation exacerbates disease by intensifying neutrophil dysregulation, excessive NET accumulation, and impaired resolution of infection in an already compromised host environment. These findings underscore the importance of host-pathogen interactions in shaping infection severity and suggest that targeting pathogen regulatory pathways may be particularly effective in settings of immune dysfunction such as diabetes.

Authors

Institutions

Publication Details

Journal
mBio
Published
2026-06-09
DOI
https://doi.org/10.1128/mbio.00486-26
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ClpX-dependent regulatory pathway exacerbates Streptococcus pyogenes pathogenesis in diabetic skin infection

Wei Xu, Scott J. Hultgren, Shuiqiao Liu, Michael G. Caparon et al.
mBio
Streptococcal Infections and Treatments
article

ClpX-dependent regulatory pathway exacerbates Streptococcus pyogenes pathogenesis in diabetic skin infection

Wei Xu, Scott J. Hultgren, Shuiqiao Liu, Michael G. Caparon, Anne Rosén, Benjamin Olson, Andrew L. Kau, Suzanne Hickerson, Yongke Lu
article en

Abstract

ABSTRACT Diabetes is associated with impaired immune function and increased susceptibility to severe bacterial infections, yet the pathogen-encoded mechanisms that exacerbate disease in this context remain poorly defined. Streptococcus pyogenes (group A Streptococcus [GAS]) causes invasive skin and soft tissue infections that are disproportionately severe in individuals with diabetes, often accompanied by delayed healing, excessive inflammation, and polymicrobial overgrowth. Here, we investigated how the GAS ClpX-dependent regulatory pathway (CDRP), a global virulence regulator, interacts with diabetic immune dysfunction to shape infection outcomes. Using two murine models of type I diabetes, we show that diabetic mice develop more severe and persistent GAS skin infections characterized by increased bacterial burden, exaggerated inflammatory responses, impaired neutrophil recruitment, excessive neutrophil extracellular trap (NET) accumulation, and frequent polymicrobial infections. Deletion of clpX significantly attenuated GAS virulence in both diabetic and non-diabetic hosts; however, the pathogenic consequences of CDRP were markedly amplified in the diabetic environment. In diabetic mice, CDRP promoted sustained inflammation, altered neutrophil behavior, impaired NET clearance, and enhanced tissue damage, leading to delayed resolution of infection. Mechanistically, ClpX-dependent virulence was associated with dysregulated protease-nuclease activity, excessive NET persistence, and defective neutrophil chemotaxis within diabetic lesions. Together, these findings indicate that while ClpX is a core regulator of GAS virulence, its downstream effects are disproportionately deleterious when host immune clearance is compromised. IMPORTANCE Diabetic patients experience disproportionately severe bacterial infections, yet the microbial mechanisms that exacerbate disease in this immunocompromised context remain incompletely understood. This study demonstrates that the Streptococcus pyogenes ClpX-dependent regulatory pathway, a central regulator of virulence, amplifies tissue damage and inflammatory dysfunction during diabetic skin infection. ClpX-dependent regulation exacerbates disease by intensifying neutrophil dysregulation, excessive NET accumulation, and impaired resolution of infection in an already compromised host environment. These findings underscore the importance of host-pathogen interactions in shaping infection severity and suggest that targeting pathogen regulatory pathways may be particularly effective in settings of immune dysfunction such as diabetes.

mBio
University of Washington (US), Marshall University (US)
Marshall University Joan C. Edwards School of Medicine, West Virginia Clinical and Translational Science Institute, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 6%
Streptococcal Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.